Blood pressure lowering effect of lactotripeptides assumed as functional foods: A meta-analysis of current available clinical trials

Journal of Human Hypertension

Volumn 25, Issue 7, 2011, Pages 425-436

  Cicero, A F G ^a   Gerocarni, B ^a   Laghi, L ^a   Borghi, C ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

blood pressure; lactotripeptides; meta analysis; placebo controlled trials

Indexed keywords

ISOLEUCINE; NUTRACEUTICAL; PLACEBO; PROLINE; TRIPEPTIDE; VALINE;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DRUG EFFECT; FEMALE; FUNCTIONAL FOOD; HUMAN; HYPERTENSION; MALE; MEDLINE; META ANALYSIS; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OLIGOPEPTIDES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79959288378     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.85     Document Type: Article

References (40)

1. Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation 2005; 112: 3547-3553 (Pubitemid 43739531)
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223 (Pubitemid 40138015)
3. Lawes CM, Vanders HS, Rodgers A. Global burden of blood-pressure related disease, 2001. Lancet 2008; 371: 1513-1518
4. McInnes GT. Lowering blood pressure for cardiovascular risk reduction. J Hypertens Suppl 2005; 23: S3-S8
5. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25(6): 1105-1187 (Pubitemid 46924065)
6. Appel LJ, Giles TD, Black HR, Izzo Jr JL, Materson BJ, Oparil S, et al., American Society of Hypertension Writing Group. ASH position paper: dietary approaches to lower blood pressure. J Clin Hypertens 2009; 11(7): 358-368
7. Miller III ER, Erlinger TP, Appel LJ. The effects of macronutrients on blood pressure and lipids: an overview of the DASH and OmniHeart trials. Curr Atheroscler Rep 2006; 8(6): 460-465 (Pubitemid 44697798)
8. Pérez-López FR, Chedraui P, Haya J, Cuadros JL. Effects of the Mediterranean diet on longevity and age-related morbid conditions. Maturitas 2009; 64(2): 67-79
9. Pripp AH. Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials. Food Nutr Res 2008; 52: 1-9
10. Murray BA, FitzGerald RJ. Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Curr Pharm Des 2007; 13: 773-791 (Pubitemid 46591099)
11. FitzGerald RJ, Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr 2000; 84(Suppl. 1): S33-S37 (Pubitemid 32106827)
12. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 1996; 64: 767-771 (Pubitemid 26398281)
13. Kajimoto O, Nakamura Y, Yada H, Moriguchi S, Hirata H, Takahashi T. Hypotensive effect of sour milk in subjects with mold or moderate hypertension. J Jpn Soc Nutr Food Sci 2001; 54: 347-354
14. Kajimoto O, Aihara K, Hirata H, Takahashi R, Nakamura Y. Hypotensive effects of the tablets containing Lactotripeptides (VPP, IPP). J Nutr Food 2001; 4(3): 51-61
15. Hirata H, Nakamura Y, Yada H, Moriguchi S, Kajimoto O, Takahashi T. Clinical effect of new sour milk drink on mild or moderate hypertensive subjects. J New Rem Clin 2002; 51(1): 61-69
16. Seppo L, Kerojoki O, Suomalainen T, Korpela R. The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension: a pilot study on humans. Milchwissenschaft 2002; 57: 124-127 (Pubitemid 34881652)
17. Seppo L, Jauhiainen T, Poussa T, Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 2003; 77: 326-330 (Pubitemid 36133373)
18. Mizushima S, Ohshige K, Watanabe J, Kimura M, Kadowaki T, Nakamura Yet al. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am J Hypertens 2004; 17: 701-706 (Pubitemid 39091551)
19. Tuomilehto J, Lindstrom J, Hyyrynen J, Korpela R, Karhunen M-L, Mikkola L et al. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with milk hypertension. J Hum Hypertens 2004; 18: 795-802 (Pubitemid 39530092)
20. Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 2005; 24: 257-265
21. Jauhiainen T, Vapaatalo H, Poussa T, Kyronpalo S, Rasmussen M, Korpela R. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens 2005; 18: 1600-1605 (Pubitemid 41814682)
22. Mizuno S, Matsuura K, Gotou T, Nishimura S, Kajimoto O, Yabune M et al. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br J Nutr 2005; 94: 84-91 (Pubitemid 41357814)
23. Sano J, Ohki K, Higuchi T, Aihara K, Mizuno S, Kajimoto O et al. Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. J Med Food 2005; 8: 423-430 (Pubitemid 43121892)
24. Engberink MF, Schouten EG, Kok FJ, van Mierlo LAJ, Brouwer IA, Geleijnse JM. Lactotripeptides show no effect on human blood pressure: results from a doubleblind randomized controlled trial. Hypertension 2008; 51(2): 399-405 (Pubitemid 351159956)
25. van der Zander K, Bots ML, Bak AAA, Koning MMG, de Leeuw PW. Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects. Am J Clin Nutr 2008; 88: 1697-1702
26. van Mierlo LAJ, Koning MMG, van der Zander K, Draijer R. Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies. Am J Clin Nutr 2009; 89: 617-623
27. de Leeuw PW, van der Zander K, Kroon AA, Rennenberg RM, Koning MM. Dose-dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects. Blood Press 2009; 18(1-2): 44-50
28. Yoshizawa M, Maeda S, Miyaki A, Misono M, Choi Y, Shimojo N et al. Additive beneficial effects of lactotripeptides and aerobic exercise on arterial compliance in postmenopausal women. Am J Physiol Heart Circ Physiol 2009; 297(5): H1899-H1903
29. Cicero AFG, Rosticci M, Veronesi M, Bacchelli S, Strocchi E, Melegari C et al. Haemodynamic effects of lactotripeptides from fermentation by lactobacillus helveticus in normotensive subjects and patients with high-normal blood pressure: a randomized, double-blind, cross-over clinical trial. J Med Food 2010 (in press)
30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188 (Pubitemid 17189972)
31. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560 (Pubitemid 37088507)
32. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634 (Pubitemid 27387172)
33. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for Meta-Analysis in Medical Research. John Wiley & Sons: Chichester, UK, 2000
34. Bax L, Yu LM, Ikeda N, Tsuruta N, Moons KGM. MIX: comprehensive free software for meta-analysis of causal research data. Version 1.54; 2006 (www.mixfor- meta-analysis.info)
35. Xu JY, Qin LQ, Wang PY, Li W, Chang C. Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition 2008; 24(10): 933-940
36. Verdecchia P, Angeli F, Mazzotta G, Ambrosio G, Reboldi G. Angiotensin receptor blockers in hypertension. New insights from Japan. Hypertens Res 2010; 33(5): 394-397
37. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al., Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007; 369(9567): 1090-1098 (Pubitemid 46483662)
38. Law MR, Morris JK, Wald NJ. Use of Blood Pressure Lowering Drugs in the Prevention of Cardiovascular Disease: Meta-analysis of 147 Randomised Trials in the Context of Expectations from Prospective Epidemiological Studies. BMJ 2009; 338: b1665
39. Nakamura T, Mizutani J, Sasaki K, Yamamoto N, Takazawa K. Beneficial potential of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro on central blood pressure and hemodynamic index: a preliminary study. J Med Food 2009; 12(6): 1-6
40. Geleijnse JM, Engberink MF. Lactopeptides and human blood pressure. Curr Opin Lipidol 2010; 21(1): 58-63